Home›Companies›Healthcare›PanGIA Biotech

Pangia Biotech, Inc.

Develops urine-based cancer tests for clinicians and patients.

Updated Nov 10, 2026·Latest SEC filing May 11, 2026·Suggest an edit

About PanGIA Biotech

PanGIA Biotech is a private company based in Delray Beach, Florida, incorporated in 2023 in Florida. It has reported $1,580,000 raised in one offering on Form D since May 2026. Its chief executive is Holly Magliochetti.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 8, 2026May 11, 2026$1,580,000fully sold18$87,778Debt, OptionsRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on PanGIA Biotech's Form D filed May 11, 2026.

OP
Obdulio Piloto
Chief Scientific Officer and Co-Founder
GR
Garth Lees-Rolfe
Audit Committee Chair
Caroline Popper
Caroline Popper
Strategic Advisor, Commercialization & Market Access
HM
Holly Magliochetti
CEO and Co-Founder, director

Sources

  1. SECPANGIA BIOTECH, INC. filing history
  2. CompanyOur story
  3. CompanyStrategic advisors
  4. CompanyProstate cancer study announcement